ArticleProceedings of the National Academy of Sciences of the United States of America2020

FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.

Elaine Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.